LUTS - BPH

2008

Daily Use of PDE5-Inhibitors: The Road to Happiness? 
Gratzke C 
Based on:
Endothelial Rehabilitation: The Impact of Chronic PDE5 Inhibitors on Erectile Function and Protein Alterations in Cavernous Tissue of Diabetic Rats 
De Young LX, Domes T, Lim KB et al

Prostate Cancer Following BPH Treatments: What the Patient Should Know 
Gilling PJ 
Based on:
Nerve-Sparing Radical Retropubic Prostatectomy in Patients Previously Submitted to Holmium Laser Enucleation of the Prostate for Bladder Outlet Obstruction Due to Benign Prostatic Enlargement 
Suardi N, Scattoni V, BrigantiA, et al

Phosphodiesterase Type 5 Inhibitors Improve Male Lower Urinary Tract Symptoms 
Giuliano F 
Rebuttal from Author re: François Giuliano. Phosphodiesterase Type 5 Inhibitors Improve Male Lower Urinary Tract Symptoms. Eur Urol 2008;53:1121–3 
Stief CG
The above two editorials are based on the following article:
A Randomised, Placebo-Controlled Study to Assess the Efficacy of Twice-Daily Vardenafil in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia 
Stief CG, Porst H, Neuser D et al

Red Wine, Sex, and a Genius 
Bartoletti R,  Mondaini N, Cai T

2007

Medical Management of BPH: The Debate Continues 
Debruyne FMJ

Drug treatment for LUTS and BPH: New is not always better 
Roehrborn CG

Lasers for the Treatment of Bladder Outlet Obstruction: Are They Challenging Conventional Treatment Modalities? 
de la Rosette J, Alivizatos G

Laser Vaporization of the Prostate: Are We there Yet? 
Gilling PJ
Based on:
The diode laser: a novel side-firing approach for laser vaporisation of the human
prostate - immediate efficacy and 1-year follow-up

Seitz, Sroka, Gratzke et al.

eXTReMe Tracker